Diamond Hill Capital Management LLC Investment Advisor Purchases New Stake in Perrigo Company plc $PRGO

Key Points

• Diamond Hill Capital Management purchased 391,340 shares of Perrigo, valued at approximately $4.1 million, giving it a 0.28% stake. Institutional investors collectively own 95.91% of the company.
• Perrigo reported quarterly earnings of $0.50 per share, beating estimates of $0.39, while revenue of $1.02 billion matched expectations but declined 3.1% year over year.
• The company declared a quarterly dividend of $0.29 per share, representing an annualized payout of $1.16 and a roughly 9.0% yield. Analysts’ consensus rating remains “Hold,” with a target price of $19.33.

Diamond Hill Capital Management LLC Investment Advisor bought a new position in Perrigo Company plc (NYSE:PRGO - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 391,340 shares of the company's stock, valued at approximately $4,066,000. Diamond Hill Capital Management LLC Investment Advisor owned about 0.28% of Perrigo as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Amundi boosted its position in shares of Perrigo by 11.7% during the first quarter. Amundi now owns 5,292 shares of the company's stock worth $148,000 after buying an additional 556 shares during the period. Goldman Sachs Group Inc. boosted its stake in Perrigo by 126.6% during the first quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company's stock valued at $32,520,000 after buying an additional 647,982 shares in the last quarter. United Services Automobile Association acquired a new position in shares of Perrigo in the 1st quarter worth approximately $250,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Perrigo by 6.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 513,112 shares of the company's stock valued at $14,388,000 after purchasing an additional 32,151 shares during the last quarter. Finally, Geneos Wealth Management Inc. boosted its holdings in Perrigo by 439.1% during the first quarter. Geneos Wealth Management Inc. now owns 965 shares of the company's stock worth $27,000 after buying an additional 786 shares in the last quarter. Institutional investors own 95.91% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on PRGO. Weiss Ratings raised Perrigo from a "sell (d-)" rating to a "sell (d)" rating in a report on Thursday, August 6th. Wall Street Zen raised shares of Perrigo from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Finally, Zacks Research raised Perrigo from a "strong sell" rating to a "hold" rating in a research report on Monday, April 27th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $19.33.

Perrigo Stock Down 1.2%

Shares of PRGO stock opened at $12.89 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 2.32 and a debt-to-equity ratio of 1.31. Perrigo Company plc has a 12 month low of $9.23 and a 12 month high of $24.60. The stock has a 50 day moving average of $10.86 and a 200-day moving average of $11.43. The firm has a market cap of $1.79 billion, a PE ratio of -1.03, a price-to-earnings-growth ratio of 1.49 and a beta of 0.51.

Perrigo (NYSE:PRGO - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share for the quarter, topping analysts' consensus estimates of $0.39 by $0.11. The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%.The firm's revenue for the quarter was down 3.1% compared to the same quarter last year. During the same period last year, the business earned ($0.06) earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, equities analysts predict that Perrigo Company plc will post 2.2 EPS for the current year.

Perrigo Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Friday, August 28th will be paid a $0.29 dividend. This represents a $1.16 annualized dividend and a dividend yield of 9.0%. The ex-dividend date is Friday, August 28th. Perrigo's dividend payout ratio is currently -9.27%.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo's focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo's operations span research and development, manufacturing, quality assurance and global distribution.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source